Tauroursodeoxycholic acid (TUDCA)
Tauroursodeoxycholic Acid (TUDCA) · also known as TUDCA, Tauroursodeoxycholic acid
Tauroursodeoxycholic acid is an endogenous hydrophilic bile acid. Animal studies show it can reduce endoplasmic reticulum stress. A human trial at 1750 mg/day found only some insulin sensitivity measures improved, and ER stress markers in tissue showed no change.
Clinical uses and human evidence
Blood sugar and insulin resistance
Fatty liver and liver enzymes
Mechanisms of action
Chaperone relief of ER stress and improved bile acid flow
TUDCA can reduce ER stress markers in diabetic mice and in cell studies. In a randomized trial of 20 people, 1750 mg/day improved some insulin sensitivity measures, but stress markers in muscle and fat tissue did not change, so a molecular chaperone effect in humans has not been confirmed.
Epithelial tight junction (ZO-1 / Occludin) reinforcement and barrier repair
Evidence for improved intestinal tight junctions comes mainly from mice on a high-fat diet and from colitis models. TUDCA can restore some tight junction-related gene expression and reduce the downregulation of ZO-1 and occludin. No reliable human study has directly measured tight junction proteins at routine oral doses.